Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-036080

Director sold 4,733 shares at an average $17.19 ($81,367)

  • Director acquired 8,289 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brennan Aoife · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-07 Grant or award : show line 1 in the form 10b5-1 +8,289 32,680 D
2023-06-09 Sale : show line 2 in the form 10b5-1 −1,994 $16.74 $33,380 30,686 D
2023-06-09 Sale : show line 3 in the form 10b5-1 −2,739 $17.52 $47,987 27,947 D
Open-market sales · 4,733 sh · avg $17.19 · $81,367

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-07 Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) +12,666 12,666 D
Loading xslF345X04/doc4.xml…